Clinical trial
Impact of Empaglifozine on Cardiac Ectopic Fat
NCT03118336 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Empaglifozine on Cardiac Ectopic Fat
- Lead sponsor
- Assistance Publique Hopitaux De Marseille
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 16, 2017
- Completion date
- February 7, 2020
- Enrollment
- 56 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes